ArticleJournal of hepatocellular carcinoma2026
Pathologic Complete Response to Neoadjuvant Dual Checkpoint Blockade with Durvalumab Plus Tremelimumab in Advanced-Stage HCC: A Case Report.
Leonard Bopp et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.